Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Richman

Showing results (81-90 of 210) with videos related to

Pageof 21
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1988
Monoclonal anti-idiotopic antibodies against myasthenia-inducing anti-acetylcholine receptor monoclonal antibodies. Preponderance of nonparatope-directed antibodies affecting antigen bindingM A Agius, C J Geannopoulos, R H Fairclough, et al.
Neurology|March 1, 1979
Cellular immunity to acetylcholine receptor in myasthenia gravis: relationship to histocompatibility type and antigenic siteD P Richman, J P Antel, J W Patrick, et al.
Annals of Neurology|June 1, 1981
Myasthenia induced by monoclonal anti-acetylcholine receptor antibodies: clinical and electrophysiological aspectsS A Burres, J W Crayton, C M Gomez, et al.
Neurology|September 1, 1978
Lymphocyte function and the role of regulator cells in multiple sclerosisJ P Antel, D P Richman, M E Medof, et al.
Annals of the New York Academy of Sciences|January 1, 1981
Nicotinic acetylcholine receptor on human lymphocytesD P Richman, J P Antel, J B Burns, et al.
Journal of the Neurological Sciences|May 3, 2011
Accelerated central nervous system autoimmunity in BAFF-receptor-deficient miceSusan S Kim, David P Richman, Scott S Zamvil, et al.
Annals of Neurology|May 1, 1982
Defective mitogenic responses in myasthenia gravis and multiple sclerosisE J Dropcho, D P Richman, J P Antel, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|April 19, 2017
Acute Stroke Despite Dabigatran Anticoagulation Treated with Idarucizumab and Intravenous Tissue Plasminogen ActivatorDavid Bissig, Rashmi Manjunath, Brittany R Traylor, et al.
Thrombosis Journal|April 11, 2023
Antibiotic use in acute mesenteric ischemia: a review of the evidence and call to actionYuqian Tian, Sanjeev Dhara, Christopher D Barrett, et al.
American Journal of Clinical Oncology|December 11, 1991
Lung carcinoma in 1,336 patientsK S Sridhar, W Raub, R C Duncan, et al.
Pageof 21

Showing results (81-90 of 210) with videos related to

Sort By:
Pageof 21
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1988
Monoclonal anti-idiotopic antibodies against myasthenia-inducing anti-acetylcholine receptor monoclonal antibodies. Preponderance of nonparatope-directed antibodies affecting antigen bindingM A Agius, C J Geannopoulos, R H Fairclough, et al.
Neurology|March 1, 1979
Cellular immunity to acetylcholine receptor in myasthenia gravis: relationship to histocompatibility type and antigenic siteD P Richman, J P Antel, J W Patrick, et al.
Annals of Neurology|June 1, 1981
Myasthenia induced by monoclonal anti-acetylcholine receptor antibodies: clinical and electrophysiological aspectsS A Burres, J W Crayton, C M Gomez, et al.
Neurology|September 1, 1978
Lymphocyte function and the role of regulator cells in multiple sclerosisJ P Antel, D P Richman, M E Medof, et al.
Annals of the New York Academy of Sciences|January 1, 1981
Nicotinic acetylcholine receptor on human lymphocytesD P Richman, J P Antel, J B Burns, et al.
Journal of the Neurological Sciences|May 3, 2011
Accelerated central nervous system autoimmunity in BAFF-receptor-deficient miceSusan S Kim, David P Richman, Scott S Zamvil, et al.
Annals of Neurology|May 1, 1982
Defective mitogenic responses in myasthenia gravis and multiple sclerosisE J Dropcho, D P Richman, J P Antel, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|April 19, 2017
Acute Stroke Despite Dabigatran Anticoagulation Treated with Idarucizumab and Intravenous Tissue Plasminogen ActivatorDavid Bissig, Rashmi Manjunath, Brittany R Traylor, et al.
Thrombosis Journal|April 11, 2023
Antibiotic use in acute mesenteric ischemia: a review of the evidence and call to actionYuqian Tian, Sanjeev Dhara, Christopher D Barrett, et al.
American Journal of Clinical Oncology|December 11, 1991
Lung carcinoma in 1,336 patientsK S Sridhar, W Raub, R C Duncan, et al.
Pageof 21